Graham George 4

What Happened
Graham George, Senior Vice President and Chief R&D Officer of Balchem Corporation (BCPC), was granted 700 restricted shares and a 2,600-share derivative award (option grant) on February 11, 2026. Both grants show an acquisition price of $0.00, indicating these were compensation awards rather than purchases; total cash exchanged for these awards in this filing was $0.

Key Details

• Transaction date: February 11, 2026; Form 4 filed February 13, 2026 (within normal two‑business‑day reporting window).
• Grants: 700 restricted shares (restricted stock) and 2,600 derivative shares (option grant). Reported price: $0.00 for both. Transaction code: A (award/grant).
• Shares owned after transaction: Not specified in the information provided in this summary/Form 4 excerpt.
• Vesting/other terms: Restricted stock vests over 3 years (25% at year 1, 25% at year 2, 50% at year 3) per footnote F1. Options vest 20% in Year 1, 40% in Year 2, and 40% in Year 3 per footnote F2. Restrictions on transfer apply per the Restricted Stock Grant Agreement.
• No sale or cashless exercise reported here; this is a compensation grant.

Context
A $0.00 grant is standard for executive compensation awards and does not represent a market purchase or sale. The derivative portion is an option-style award that vests over time, so any future sale or exercise would generate a separate filing. Such awards are typically retention/compensation mechanisms and should not be interpreted on their own as a buy or sell signal.